Cytokinetics presents aficamten data at cardiology congress
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 9/3/2026
- Wall St ends higher as stocks reclaim some shine
- Broadcom raises AI chip forecast as Big Tech keeps writing bigger checks
- Snowflake soars 20% on earnings beat and raised guidance
- Oil settles 1% higher, as US-Iran strikes threaten supplies
- Could Apple’s foldable iPhone be a $14B opportunity? Morgan Stanley weighs in
Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025
August 31, 2025 12:10 PM EDTAdditional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American College of Cardiology
New Analysis Shows Annual Incidence Rate of Atrial Fibrillation with Aficamten is 1.5%, Consistent with Expected Rates in Prediction Model of Patients with HCM; Simultaneous Publication in Heart Rhythm
Longer-Term Data Presented Consistent with Previously Reported Safety Profile of Aficamten
Company to Host Investor Event and Webcast Tuesday September 2, 2025, at 8:30 AM Eastern Time
SOUTH SAN... More
